drugset / Trial / NCT03035305
Seasonal Malaria Chemoprevention With or Without Lipid-based Nutrient Supplement in Children Aged 6-59 Months in Mali
Completed
36717 enrolled
Alliance for International Medical Action
Alliance médicale contre le paludisme, Mali · collabEuropean Commission · collabInstitut National de la Santé Et de la Recherche Médicale, France · collabMinistry of health, Mali · collabProgramme National de Lutte contre le Paludisme, Niger · collabUnited States Agency for International Development (USAID) · collab
Non-randomizedParallel-groupOpen-labelPrevention
Summary
SMC LNS Mali is a interventional matched-pair clustered cohort carried out between August and November 2017 in 18 health areas in Kolokani Circle, Koulikoro region, Mali. The objective of this study is to determine whether the association SMC and LNS reduces the number of confirmed malaria cases among children 6-59 months during the monthly SMC distribution sessions.
Timeline
- Start
- 2016-08
- Primary completion
- 2016-11
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | amodiaquine | Other / unclassified | 75 mg | — |
| Subject | amodiaquine | Other / unclassified | 150 mg | — |
| Subject | pyrimethamine | Small molecule | 12.5 mg | — |
| Subject | pyrimethamine | Small molecule | 25 mg | — |
| Subject | sulfadoxine | Small molecule | 250 mg | — |
| Subject | sulfadoxine | Small molecule | 500 mg | — |